StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
OXIQUIM.SN$12441.00+0.00%
Fair $12441.00+0.0%

OXIQUIM.SN

Oxiquim S.A.

Basic Materials / ChemicalsSantiago

$12441.00

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $12441.00Fund rank 33/100 · Data gapFallback financials|
SA 51/C
F-Score: 4/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 24% · confianza 25%

FCF escenarios

weak_data · normalized FCF $22.9B · quality 65.3/100

Data gap 33/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 62/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

51/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · OXIQUIM.SNLocal privado en este navegador · Oxiquim S.A.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$309.6B

P/E

10033.1x

↑

EV/EBITDA

9.5x

↓

ROE

21.3%

↑

Gross Margin

34.8%

↑

Debt/Equity

0.50

↑
52-Week Range$12441
$9000$13800

TradingView lightweight chart

OXIQUIM.SN price, volumen y niveles de valoración

Último $12,441Periodo +522.1%
Fair value: $12,441

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-3.6%

FCF CAGR

+88.1%

FCF margin

9.7%

FCF / Net income

0.88x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $236.76B · net income $26.09B · FCF $22.95B

2022-FY → 2025-FY

Gross margin

34.8%+3.5% pts

Operating margin

12.8%-0.2% pts

Net margin

11.0%+0.0% pts

FCF margin

9.7%+8.4% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$236.76B$236.76B$235.35B$214.65B$264.70B
Net Income$26.09B$26.09B$26.32B$23.90B$29.06B
EBITDA$37.71B$37.71B$39.62B$36.14B$41.52B
EPS——1.060.961167.70
Gross Margin34.8%34.8%36.2%35.7%31.3%
Operating Margin12.8%12.8%14.5%13.2%13.0%
Net Margin11.0%11.0%11.2%11.1%11.0%
Balance Sheet
Debt/Equity0.500.500.510.560.69
Current Ratio1.531.53———
Cash Flow
Free Cash Flow$22.95B$22.95B$18.85B$26.41B$3.45B
Returns
ROE21.3%21.3%22.5%22.2%29.4%
Valuation
P/E10033.0610033.067754.146780.365.44
EV/EBITDA9.509.506.445.895.27
P/B2.532.531.751.511.60
Growth & Yield
Revenue Growth0.6%0.6%9.6%-18.9%—
EPS Growth——10.1%-99.9%—
Dividend Yield8.7%8.7%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +38.3%

Total return

+38.3%

Start / end P/E

n/dx → n/dx

EPS bridge

1.06 → n/d

Residual

+29.6%

EPS growthn/d
Multiple reratingn/d
Dividend+8.7%
Residual / FX / buybacks / cross-term+29.6%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.